/
HUMA
$0.55-$0.11 (-17.29%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$179.3M
270M shares
52-week range
$0.55 – $2.55
0% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-11.65
Humacyte, Inc. Common Stock
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
www.humacyte.com- Employees
- 184
- IPO / List date
- Aug 27, 2021
- HQ
- DURHAM, NC
Held by traders on TradeandTell
No one on the platform currently holds HUMA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-06-30 | 600,300 | $2.9M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HUMA yet.
